

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.58985960 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58985960 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.25634978 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25634978 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.88944899 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.28825708 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.28260175 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.28260175 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.28260175 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.16944475 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.94319167 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.88197462 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.87044302 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.72335037 |
| 15 | cysteine metabolic process (GO:0006534) | 5.65684367 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42943534 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 5.42013867 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.42013867 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 5.27726269 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.26032611 |
| 21 | urea metabolic process (GO:0019627) | 5.24898534 |
| 22 | urea cycle (GO:0000050) | 5.24898534 |
| 23 | lysine catabolic process (GO:0006554) | 5.08854833 |
| 24 | lysine metabolic process (GO:0006553) | 5.08854833 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.06241181 |
| 26 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.05867834 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 5.03813674 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 4.99528541 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.98441362 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.94560615 |
| 31 | protein carboxylation (GO:0018214) | 4.94560615 |
| 32 | bile acid metabolic process (GO:0008206) | 4.92873281 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.90407179 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.90318376 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.88751766 |
| 36 | regulation of fibrinolysis (GO:0051917) | 4.84693086 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.80695225 |
| 38 | alpha-amino acid catabolic process (GO:1901606) | 4.74555945 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 4.66904781 |
| 40 | respiratory electron transport chain (GO:0022904) | 4.64603499 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.64587203 |
| 42 | coenzyme catabolic process (GO:0009109) | 4.62660400 |
| 43 | regulation of complement activation (GO:0030449) | 4.58906555 |
| 44 | electron transport chain (GO:0022900) | 4.58578608 |
| 45 | serine family amino acid metabolic process (GO:0009069) | 4.58368331 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.58048595 |
| 47 | cellular biogenic amine catabolic process (GO:0042402) | 4.57900754 |
| 48 | amine catabolic process (GO:0009310) | 4.57900754 |
| 49 | serine family amino acid biosynthetic process (GO:0009070) | 4.57029456 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 4.50536981 |
| 51 | glycine metabolic process (GO:0006544) | 4.49475659 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 4.45971577 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.42651728 |
| 54 | regulation of cholesterol esterification (GO:0010872) | 4.40914162 |
| 55 | reverse cholesterol transport (GO:0043691) | 4.39680412 |
| 56 | proteasome assembly (GO:0043248) | 4.34599798 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 4.33414390 |
| 58 | protein-lipid complex remodeling (GO:0034368) | 4.33414390 |
| 59 | macromolecular complex remodeling (GO:0034367) | 4.33414390 |
| 60 | cellular modified amino acid catabolic process (GO:0042219) | 4.27306390 |
| 61 | cellular glucuronidation (GO:0052695) | 4.26500864 |
| 62 | aldehyde catabolic process (GO:0046185) | 4.26281993 |
| 63 | urate metabolic process (GO:0046415) | 4.26254126 |
| 64 | glutamate metabolic process (GO:0006536) | 4.25063493 |
| 65 | acylglycerol homeostasis (GO:0055090) | 4.25007959 |
| 66 | triglyceride homeostasis (GO:0070328) | 4.25007959 |
| 67 | negative regulation of cholesterol transport (GO:0032375) | 4.18654470 |
| 68 | negative regulation of sterol transport (GO:0032372) | 4.18654470 |
| 69 | drug transmembrane transport (GO:0006855) | 4.18594510 |
| 70 | drug catabolic process (GO:0042737) | 4.17995775 |
| 71 | ethanol oxidation (GO:0006069) | 4.17524495 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 4.10297329 |
| 73 | plasma lipoprotein particle clearance (GO:0034381) | 4.07886481 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 4.06930146 |
| 75 | bile acid and bile salt transport (GO:0015721) | 4.05297164 |
| 76 | ketone body metabolic process (GO:1902224) | 4.03802322 |
| 77 | short-chain fatty acid metabolic process (GO:0046459) | 3.98657199 |
| 78 | aspartate family amino acid catabolic process (GO:0009068) | 3.98132523 |
| 79 | phospholipid efflux (GO:0033700) | 3.98007413 |
| 80 | imidazole-containing compound metabolic process (GO:0052803) | 3.95314509 |
| 81 | arginine metabolic process (GO:0006525) | 3.94138154 |
| 82 | cholesterol efflux (GO:0033344) | 3.88346125 |
| 83 | cofactor catabolic process (GO:0051187) | 3.87963835 |
| 84 | organic acid catabolic process (GO:0016054) | 3.87505759 |
| 85 | carboxylic acid catabolic process (GO:0046395) | 3.87505759 |
| 86 | glucuronate metabolic process (GO:0019585) | 3.87039996 |
| 87 | uronic acid metabolic process (GO:0006063) | 3.87039996 |
| 88 | heme transport (GO:0015886) | 3.86076879 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.85458180 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72270316 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.71678774 |
| 92 | respiratory chain complex IV assembly (GO:0008535) | 3.71062214 |
| 93 | fibrinolysis (GO:0042730) | 3.69926437 |
| 94 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68865428 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.67704751 |
| 96 | very long-chain fatty acid metabolic process (GO:0000038) | 3.62821371 |
| 97 | L-serine metabolic process (GO:0006563) | 3.62582614 |
| 98 | protein complex biogenesis (GO:0070271) | 3.60197641 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 3.59760914 |
| 100 | fatty acid beta-oxidation (GO:0006635) | 3.57662675 |
| 101 | DNA deamination (GO:0045006) | 3.56960320 |
| 102 | response to nitrosative stress (GO:0051409) | 3.56206836 |
| 103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.55070163 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55070163 |
| 105 | monocarboxylic acid catabolic process (GO:0072329) | 3.54709833 |
| 106 | fatty acid oxidation (GO:0019395) | 3.53138227 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.52326026 |
| 108 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.52263784 |
| 109 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.50886088 |
| 110 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.50886088 |
| 111 | lipid oxidation (GO:0034440) | 3.49517878 |
| 112 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.46282328 |
| 113 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.44245734 |
| 114 | hydrogen ion transmembrane transport (GO:1902600) | 3.40329746 |
| 115 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.38332253 |
| 116 | NADH dehydrogenase complex assembly (GO:0010257) | 3.38332253 |
| 117 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.38332253 |
| 118 | cytochrome complex assembly (GO:0017004) | 3.38154675 |
| 119 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.34071889 |
| 120 | oxidative phosphorylation (GO:0006119) | 3.30502781 |
| 121 | protein neddylation (GO:0045116) | 3.29736393 |
| 122 | proton transport (GO:0015992) | 3.18954092 |
| 123 | hydrogen transport (GO:0006818) | 3.16211044 |
| 124 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.11285978 |
| 125 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.10149664 |
| 126 | ATP biosynthetic process (GO:0006754) | 3.05987665 |
| 127 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.05897120 |
| 128 | signal peptide processing (GO:0006465) | 3.04058940 |
| 129 | platelet dense granule organization (GO:0060155) | 2.97573241 |
| 130 | vitamin biosynthetic process (GO:0009110) | 2.94688174 |
| 131 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.92093060 |
| 132 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.91250492 |
| 133 | organelle disassembly (GO:1903008) | 2.85754159 |
| 134 | negative regulation of ligase activity (GO:0051352) | 2.84855425 |
| 135 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.84855425 |
| 136 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.84840967 |
| 137 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.84840967 |
| 138 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.84840967 |
| 139 | epoxygenase P450 pathway (GO:0019373) | 2.82989640 |
| 140 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.82127224 |
| 141 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.82127224 |
| 142 | amino acid salvage (GO:0043102) | 2.81765461 |
| 143 | L-methionine salvage (GO:0071267) | 2.81765461 |
| 144 | L-methionine biosynthetic process (GO:0071265) | 2.81765461 |
| 145 | protein-cofactor linkage (GO:0018065) | 2.81431069 |
| 146 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.80921671 |
| 147 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.80921671 |
| 148 | ribonucleoprotein complex disassembly (GO:0032988) | 2.79401838 |
| 149 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78321788 |
| 150 | S-adenosylmethionine metabolic process (GO:0046500) | 2.71922840 |
| 151 | cytidine metabolic process (GO:0046087) | 2.71048460 |
| 152 | cytidine catabolic process (GO:0006216) | 2.71048460 |
| 153 | cytidine deamination (GO:0009972) | 2.71048460 |
| 154 | DNA replication checkpoint (GO:0000076) | 2.70415855 |
| 155 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.69335696 |
| 156 | termination of RNA polymerase III transcription (GO:0006386) | 2.69335696 |
| 157 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.67586337 |
| 158 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.67586337 |
| 159 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.62873013 |
| 160 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.62206377 |
| 161 | GPI anchor biosynthetic process (GO:0006506) | 2.61076983 |
| 162 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.61057130 |
| 163 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.61057130 |
| 164 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.59911420 |
| 165 | mannosylation (GO:0097502) | 2.58976157 |
| 166 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.57027316 |
| 167 | chaperone-mediated protein transport (GO:0072321) | 2.56588867 |
| 168 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.56111851 |
| 169 | nucleobase biosynthetic process (GO:0046112) | 2.55472963 |
| 170 | pseudouridine synthesis (GO:0001522) | 2.55396931 |
| 171 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.54996009 |
| 172 | cellular respiration (GO:0045333) | 2.54391389 |
| 173 | GPI anchor metabolic process (GO:0006505) | 2.53782781 |
| 174 | purine nucleobase biosynthetic process (GO:0009113) | 2.52967241 |
| 175 | regulation of cellular amine metabolic process (GO:0033238) | 2.51667714 |
| 176 | cullin deneddylation (GO:0010388) | 2.49620589 |
| 177 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.48874564 |
| 178 | flavonoid metabolic process (GO:0009812) | 2.48582851 |
| 179 | aerobic respiration (GO:0009060) | 2.47856064 |
| 180 | regulation of cellular respiration (GO:0043457) | 2.47195220 |
| 181 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.46712621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.14169091 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.18156690 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.94587006 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.27733709 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.01887705 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.91419213 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.74457718 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.73734508 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.22522122 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.06585076 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.82636857 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.41230666 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.86091234 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.80619601 |
| 15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.74409246 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.68521530 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.60603250 |
| 18 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.44692624 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.33529110 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.26327251 |
| 21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.25754829 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.17936287 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.13523764 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.11458708 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7565200 |
| 26 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99824095 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96554499 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96492098 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96347972 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96255604 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89613987 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81554937 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.77881853 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71494943 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.63054554 |
| 36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.56857810 |
| 37 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.56319967 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53366055 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53329781 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53066884 |
| 41 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.50903997 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49978352 |
| 43 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.48728267 |
| 44 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.48728267 |
| 45 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.48169717 |
| 46 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45708316 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45513312 |
| 48 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.44993187 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.44019275 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43517594 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.43277879 |
| 52 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.42300284 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40571227 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.36420583 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35058523 |
| 56 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.30401541 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29458165 |
| 58 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.27722989 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26802294 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26770364 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25339576 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24159054 |
| 63 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23960353 |
| 64 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20481407 |
| 65 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20451284 |
| 66 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19507626 |
| 67 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.18430797 |
| 68 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16450391 |
| 69 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.15986194 |
| 70 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.15211768 |
| 71 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15125631 |
| 72 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12733583 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12556507 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11627086 |
| 75 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.11262927 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10150488 |
| 77 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.07557837 |
| 78 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.05179311 |
| 79 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04975672 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04559793 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04248667 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04248667 |
| 83 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03959579 |
| 84 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.03753015 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03607267 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03597301 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02775230 |
| 88 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01375706 |
| 89 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.00110994 |
| 90 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.99619063 |
| 91 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99484555 |
| 92 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99312814 |
| 93 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99272474 |
| 94 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.98724434 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98670072 |
| 96 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97711404 |
| 97 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.97672049 |
| 98 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.97390502 |
| 99 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95987794 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91633015 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89626136 |
| 102 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.86232185 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84111524 |
| 104 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.82746134 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82044470 |
| 106 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.79920536 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78218558 |
| 108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77630225 |
| 109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76193646 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75837407 |
| 111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75837407 |
| 112 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.71263304 |
| 113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.69593517 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67683620 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.66842965 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66264868 |
| 117 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65880530 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65668972 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63732619 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62915763 |
| 121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.61182274 |
| 122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61086082 |
| 123 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.60969160 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.58537144 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58246512 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57999026 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57815835 |
| 128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57477887 |
| 129 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.57217427 |
| 130 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.57090417 |
| 131 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.56750106 |
| 132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.56360375 |
| 133 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55595423 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54576463 |
| 135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.53917233 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53853969 |
| 137 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53704104 |
| 138 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52846399 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52571874 |
| 140 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.51553376 |
| 141 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.50770487 |
| 142 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.50067427 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.49081934 |
| 144 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.49005290 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.48985092 |
| 146 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.47698409 |
| 147 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.46759530 |
| 148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.46657394 |
| 149 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.45871466 |
| 150 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.45628731 |
| 151 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45335772 |
| 152 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45230950 |
| 153 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.44408739 |
| 154 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43111816 |
| 155 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43095442 |
| 156 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42825325 |
| 157 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.42541304 |
| 158 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42437642 |
| 159 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42262648 |
| 160 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.41708477 |
| 161 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.40955764 |
| 162 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.40955764 |
| 163 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.39888447 |
| 164 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.39511380 |
| 165 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.39469847 |
| 166 | GATA1_22025678_ChIP-Seq_K562_Human | 0.38925689 |
| 167 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.38485854 |
| 168 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.38393164 |
| 169 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.37939190 |
| 170 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.37433423 |
| 171 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37349404 |
| 172 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.37190276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25660879 |
| 2 | MP0005360_urolithiasis | 7.94065050 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.13124668 |
| 4 | MP0005365_abnormal_bile_salt | 5.92033731 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93231454 |
| 6 | * MP0003806_abnormal_nucleotide_metabolis | 4.56744183 |
| 7 | MP0003252_abnormal_bile_duct | 3.65450930 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.27792161 |
| 9 | MP0005332_abnormal_amino_acid | 3.27518279 |
| 10 | MP0003195_calcinosis | 3.06154535 |
| 11 | MP0009840_abnormal_foam_cell | 3.00542599 |
| 12 | MP0005083_abnormal_biliary_tract | 2.86958986 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.54587857 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.37191532 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.36138999 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.07511265 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.05245956 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.01984456 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.01938694 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.95435620 |
| 21 | MP0000609_abnormal_liver_physiology | 1.95033426 |
| 22 | MP0008872_abnormal_physiological_respon | 1.86167015 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.82588037 |
| 24 | MP0009697_abnormal_copulation | 1.78980770 |
| 25 | MP0009785_altered_susceptibility_to | 1.76043696 |
| 26 | MP0005671_abnormal_response_to | 1.74643470 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.73180129 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.72010739 |
| 29 | MP0001764_abnormal_homeostasis | 1.69948537 |
| 30 | MP0003186_abnormal_redox_activity | 1.69703976 |
| 31 | MP0008058_abnormal_DNA_repair | 1.68245395 |
| 32 | MP0003868_abnormal_feces_composition | 1.65892528 |
| 33 | MP0005451_abnormal_body_composition | 1.64725978 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56524511 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.54728787 |
| 36 | MP0003011_delayed_dark_adaptation | 1.53065176 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.44419782 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.43140848 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.38330150 |
| 40 | MP0003646_muscle_fatigue | 1.35762921 |
| 41 | MP0009379_abnormal_foot_pigmentation | 1.30556529 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.26196865 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.22924185 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.22382561 |
| 45 | MP0003786_premature_aging | 1.19776875 |
| 46 | MP0002102_abnormal_ear_morphology | 1.18603721 |
| 47 | MP0005647_abnormal_sex_gland | 1.15408506 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.14854086 |
| 49 | MP0002090_abnormal_vision | 1.13659220 |
| 50 | MP0003718_maternal_effect | 1.11755891 |
| 51 | MP0000604_amyloidosis | 1.10742841 |
| 52 | MP0005408_hypopigmentation | 1.07381255 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.06432262 |
| 54 | MP0000598_abnormal_liver_morphology | 1.05292072 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.03152347 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.00492248 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.00413103 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 0.99993933 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.99600570 |
| 60 | MP0004215_abnormal_myocardial_fiber | 0.98409473 |
| 61 | MP0003329_amyloid_beta_deposits | 0.97886794 |
| 62 | MP0005410_abnormal_fertilization | 0.96113688 |
| 63 | MP0001853_heart_inflammation | 0.95261411 |
| 64 | MP0003693_abnormal_embryo_hatching | 0.95031182 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.91759734 |
| 66 | MP0004142_abnormal_muscle_tone | 0.90969119 |
| 67 | MP0005253_abnormal_eye_physiology | 0.90580176 |
| 68 | MP0001845_abnormal_inflammatory_respons | 0.89908453 |
| 69 | MP0001881_abnormal_mammary_gland | 0.89607347 |
| 70 | MP0008007_abnormal_cellular_replicative | 0.89082600 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 0.88138598 |
| 72 | MP0003690_abnormal_glial_cell | 0.87646548 |
| 73 | MP0000427_abnormal_hair_cycle | 0.86209917 |
| 74 | MP0001661_extended_life_span | 0.85125618 |
| 75 | * MP0009763_increased_sensitivity_to | 0.84676466 |
| 76 | MP0004043_abnormal_pH_regulation | 0.84459416 |
| 77 | MP0001905_abnormal_dopamine_level | 0.83659536 |
| 78 | MP0010155_abnormal_intestine_physiology | 0.82258154 |
| 79 | MP0005670_abnormal_white_adipose | 0.81588039 |
| 80 | MP0009764_decreased_sensitivity_to | 0.81007646 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.80583323 |
| 82 | MP0001756_abnormal_urination | 0.79013341 |
| 83 | MP0002452_abnormal_antigen_presenting | 0.77593992 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.77185110 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 0.76650239 |
| 86 | MP0004957_abnormal_blastocyst_morpholog | 0.75962204 |
| 87 | MP0002095_abnormal_skin_pigmentation | 0.75940194 |
| 88 | MP0005395_other_phenotype | 0.75635477 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.74566796 |
| 90 | MP0001501_abnormal_sleep_pattern | 0.74251303 |
| 91 | MP0001529_abnormal_vocalization | 0.73534910 |
| 92 | * MP0005376_homeostasis/metabolism_phenot | 0.73313891 |
| 93 | MP0005387_immune_system_phenotype | 0.71759754 |
| 94 | MP0001790_abnormal_immune_system | 0.71759754 |
| 95 | MP0008469_abnormal_protein_level | 0.71389135 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.70509277 |
| 97 | MP0000371_diluted_coat_color | 0.70010342 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.69691627 |
| 99 | MP0005025_abnormal_response_to | 0.68503963 |
| 100 | MP0000566_synostosis | 0.67689956 |
| 101 | MP0006035_abnormal_mitochondrial_morpho | 0.67645958 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.67514951 |
| 103 | MP0002254_reproductive_system_inflammat | 0.66765208 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.66247110 |
| 105 | MP0005645_abnormal_hypothalamus_physiol | 0.65882358 |
| 106 | MP0002938_white_spotting | 0.64817264 |
| 107 | MP0002723_abnormal_immune_serum | 0.64634272 |
| 108 | MP0005389_reproductive_system_phenotype | 0.64520537 |
| 109 | MP0008995_early_reproductive_senescence | 0.63479813 |
| 110 | MP0001800_abnormal_humoral_immune | 0.62445879 |
| 111 | MP0002132_abnormal_respiratory_system | 0.62434710 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.61840993 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.61663706 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.60851205 |
| 115 | MP0005535_abnormal_body_temperature | 0.57756744 |
| 116 | * MP0009765_abnormal_xenobiotic_induced | 0.56914242 |
| 117 | * MP0005266_abnormal_metabolism | 0.53887386 |
| 118 | MP0002971_abnormal_brown_adipose | 0.53416109 |
| 119 | MP0009053_abnormal_anal_canal | 0.52536113 |
| 120 | MP0005334_abnormal_fat_pad | 0.51250659 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.47049760 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.46988383 |
| 123 | MP0004381_abnormal_hair_follicle | 0.46538546 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.41428092 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.41135840 |
| 126 | MP0004130_abnormal_muscle_cell | 0.40936360 |
| 127 | MP0000538_abnormal_urinary_bladder | 0.40893528 |
| 128 | MP0009672_abnormal_birth_weight | 0.40651631 |
| 129 | MP0000920_abnormal_myelination | 0.40429423 |
| 130 | MP0001915_intracranial_hemorrhage | 0.39269551 |
| 131 | MP0002295_abnormal_pulmonary_circulatio | 0.38258789 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.37527892 |
| 133 | MP0002796_impaired_skin_barrier | 0.37446125 |
| 134 | MP0003632_abnormal_nervous_system | 0.36862141 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.36599289 |
| 136 | MP0000579_abnormal_nail_morphology | 0.36331554 |
| 137 | MP0008873_increased_physiological_sensi | 0.35578001 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.34632979 |
| 139 | MP0005448_abnormal_energy_balance | 0.34394123 |
| 140 | MP0004147_increased_porphyrin_level | 0.34304561 |
| 141 | MP0003953_abnormal_hormone_level | 0.33823342 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.31213145 |
| 143 | MP0002168_other_aberrant_phenotype | 0.30749913 |
| 144 | MP0002928_abnormal_bile_duct | 0.29767850 |
| 145 | MP0008874_decreased_physiological_sensi | 0.29035215 |
| 146 | MP0003075_altered_response_to | 0.28431392 |
| 147 | MP0003699_abnormal_female_reproductive | 0.28004965 |
| 148 | MP0001243_abnormal_dermal_layer | 0.27692933 |
| 149 | MP0006082_CNS_inflammation | 0.26829632 |
| 150 | MP0001177_atelectasis | 0.26282576 |
| 151 | MP0005166_decreased_susceptibility_to | 0.26237684 |
| 152 | MP0002135_abnormal_kidney_morphology | 0.25261842 |
| 153 | MP0000647_abnormal_sebaceous_gland | 0.23212151 |
| 154 | MP0009115_abnormal_fat_cell | 0.22696767 |
| 155 | MP0005165_increased_susceptibility_to | 0.22670318 |
| 156 | MP0005377_hearing/vestibular/ear_phenot | 0.22332952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.11796307 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.97667430 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.70229714 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.06312001 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.97173286 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.91269942 |
| 7 | Xanthomatosis (HP:0000991) | 5.86693314 |
| 8 | Hyperglycinemia (HP:0002154) | 4.88734857 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.88471632 |
| 10 | Complement deficiency (HP:0004431) | 4.83976359 |
| 11 | Hyperammonemia (HP:0001987) | 4.66797328 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 4.63542584 |
| 13 | Hyperglycinuria (HP:0003108) | 4.56589435 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.56326946 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.56326946 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.38804700 |
| 17 | Acute encephalopathy (HP:0006846) | 4.35617456 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.34634971 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.31886639 |
| 20 | Hypolipoproteinemia (HP:0010981) | 4.26131298 |
| 21 | Ketosis (HP:0001946) | 4.25579987 |
| 22 | Joint hemorrhage (HP:0005261) | 4.22354637 |
| 23 | Fat malabsorption (HP:0002630) | 4.17817914 |
| 24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.16733552 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.16514335 |
| 26 | Epidermoid cyst (HP:0200040) | 4.08766758 |
| 27 | Progressive macrocephaly (HP:0004481) | 4.01774836 |
| 28 | Mitochondrial inheritance (HP:0001427) | 3.94258849 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.87122211 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.81541334 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81166727 |
| 32 | Increased CSF lactate (HP:0002490) | 3.74360234 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.70203281 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.66734138 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57495255 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 3.53581263 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 3.53486664 |
| 38 | Hepatocellular necrosis (HP:0001404) | 3.39848000 |
| 39 | Abnormality of complement system (HP:0005339) | 3.34769413 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.34268336 |
| 41 | Steatorrhea (HP:0002570) | 3.33413685 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30779117 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.29988737 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.23763412 |
| 45 | Hepatic necrosis (HP:0002605) | 3.23744292 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 3.22041112 |
| 47 | Lipid accumulation in hepatocytes (HP:0006561) | 3.15588226 |
| 48 | Hyperbilirubinemia (HP:0002904) | 3.14274096 |
| 49 | Congenital, generalized hypertrichosis (HP:0004540) | 3.11655475 |
| 50 | Hypercholesterolemia (HP:0003124) | 3.07676608 |
| 51 | Methylmalonic acidemia (HP:0002912) | 3.07178119 |
| 52 | Gout (HP:0001997) | 3.07144547 |
| 53 | Ketoacidosis (HP:0001993) | 3.04765084 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 3.02278050 |
| 55 | Lethargy (HP:0001254) | 3.02154404 |
| 56 | Increased hepatocellular lipid droplets (HP:0006565) | 3.00611494 |
| 57 | Abnormality of alanine metabolism (HP:0010916) | 2.89027148 |
| 58 | Hyperalaninemia (HP:0003348) | 2.89027148 |
| 59 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.89027148 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.88637737 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.88637737 |
| 62 | Metabolic acidosis (HP:0001942) | 2.87401287 |
| 63 | Methylmalonic aciduria (HP:0012120) | 2.83032911 |
| 64 | Cerebral edema (HP:0002181) | 2.80327878 |
| 65 | Hypothermia (HP:0002045) | 2.78359114 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.77264290 |
| 67 | Type I transferrin isoform profile (HP:0003642) | 2.73217963 |
| 68 | Renal Fanconi syndrome (HP:0001994) | 2.72984245 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.70915273 |
| 70 | Pancreatic cysts (HP:0001737) | 2.70509661 |
| 71 | Enlarged kidneys (HP:0000105) | 2.68174975 |
| 72 | Proximal tubulopathy (HP:0000114) | 2.66361018 |
| 73 | Vascular calcification (HP:0004934) | 2.66319139 |
| 74 | Optic disc pallor (HP:0000543) | 2.62067923 |
| 75 | Lactic acidosis (HP:0003128) | 2.61867366 |
| 76 | Spontaneous abortion (HP:0005268) | 2.61556784 |
| 77 | Abnormality of vitamin B metabolism (HP:0004340) | 2.59931001 |
| 78 | Malnutrition (HP:0004395) | 2.59147667 |
| 79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58576864 |
| 80 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58576864 |
| 81 | Increased serum lactate (HP:0002151) | 2.55480696 |
| 82 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.52093918 |
| 83 | Spastic diplegia (HP:0001264) | 2.49029941 |
| 84 | Respiratory failure (HP:0002878) | 2.47507020 |
| 85 | Irritability (HP:0000737) | 2.47430388 |
| 86 | Vacuolated lymphocytes (HP:0001922) | 2.40909447 |
| 87 | Vomiting (HP:0002013) | 2.39879437 |
| 88 | Exertional dyspnea (HP:0002875) | 2.39244603 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.38804758 |
| 90 | Aplastic anemia (HP:0001915) | 2.38387160 |
| 91 | Myocardial infarction (HP:0001658) | 2.37500481 |
| 92 | Abnormality of urine glucose concentration (HP:0011016) | 2.37327775 |
| 93 | Glycosuria (HP:0003076) | 2.37327775 |
| 94 | Megaloblastic anemia (HP:0001889) | 2.36281688 |
| 95 | Skin nodule (HP:0200036) | 2.35491082 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.34799455 |
| 97 | Hypoglycemic seizures (HP:0002173) | 2.34078251 |
| 98 | Alkalosis (HP:0001948) | 2.32400974 |
| 99 | Leukodystrophy (HP:0002415) | 2.32045416 |
| 100 | Rickets (HP:0002748) | 2.30926769 |
| 101 | Abnormal gallbladder physiology (HP:0012438) | 2.29754391 |
| 102 | Cholecystitis (HP:0001082) | 2.29754391 |
| 103 | Hypochromic microcytic anemia (HP:0004840) | 2.29136397 |
| 104 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27713209 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 2.23823608 |
| 106 | Neonatal onset (HP:0003623) | 2.23091632 |
| 107 | Pancreatic fibrosis (HP:0100732) | 2.22215689 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 2.22195145 |
| 109 | Metabolic alkalosis (HP:0200114) | 2.19990178 |
| 110 | Hyperuricemia (HP:0002149) | 2.18942779 |
| 111 | Increased purine levels (HP:0004368) | 2.18942779 |
| 112 | CNS demyelination (HP:0007305) | 2.18812709 |
| 113 | Abolished electroretinogram (ERG) (HP:0000550) | 2.17924997 |
| 114 | Sensorimotor neuropathy (HP:0007141) | 2.16335963 |
| 115 | Neuroendocrine neoplasm (HP:0100634) | 2.15496668 |
| 116 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.15183865 |
| 117 | Palpitations (HP:0001962) | 2.12255901 |
| 118 | Cholelithiasis (HP:0001081) | 2.11116958 |
| 119 | Increased serum pyruvate (HP:0003542) | 2.10675455 |
| 120 | Abnormality of glycolysis (HP:0004366) | 2.10675455 |
| 121 | Molar tooth sign on MRI (HP:0002419) | 2.08307441 |
| 122 | Abnormality of midbrain morphology (HP:0002418) | 2.08307441 |
| 123 | Acanthocytosis (HP:0001927) | 2.07428550 |
| 124 | Brushfield spots (HP:0001088) | 2.07341583 |
| 125 | Opisthotonus (HP:0002179) | 2.06064218 |
| 126 | Pancreatitis (HP:0001733) | 2.05508796 |
| 127 | Tinnitus (HP:0000360) | 2.05466038 |
| 128 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.05372585 |
| 129 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03119931 |
| 130 | Increased muscle lipid content (HP:0009058) | 2.02298927 |
| 131 | Abnormal glycosylation (HP:0012345) | 2.01800444 |
| 132 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.01800444 |
| 133 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.01800444 |
| 134 | Abnormal protein glycosylation (HP:0012346) | 2.01800444 |
| 135 | Macrocytic anemia (HP:0001972) | 2.00166171 |
| 136 | Mitral stenosis (HP:0001718) | 1.96577401 |
| 137 | Confusion (HP:0001289) | 1.96133323 |
| 138 | Cerebral hemorrhage (HP:0001342) | 1.95867417 |
| 139 | Abnormality of renal resorption (HP:0011038) | 1.94625154 |
| 140 | Abnormality of proline metabolism (HP:0010907) | 1.93178983 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.93178983 |
| 142 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93097625 |
| 143 | True hermaphroditism (HP:0010459) | 1.92807305 |
| 144 | Amyloidosis (HP:0011034) | 1.91689538 |
| 145 | Abnormality of the gallbladder (HP:0005264) | 1.90673522 |
| 146 | Abnormality of vitamin metabolism (HP:0100508) | 1.90621883 |
| 147 | Late onset (HP:0003584) | 1.90573412 |
| 148 | Renal cortical cysts (HP:0000803) | 1.89416551 |
| 149 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88196798 |
| 150 | Glomerulonephritis (HP:0000099) | 1.87891353 |
| 151 | Congenital stationary night blindness (HP:0007642) | 1.87853249 |
| 152 | Spastic paraparesis (HP:0002313) | 1.87350624 |
| 153 | Reduced antithrombin III activity (HP:0001976) | 1.84856759 |
| 154 | Poor head control (HP:0002421) | 1.83396832 |
| 155 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81714867 |
| 156 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.81639440 |
| 157 | Large for gestational age (HP:0001520) | 1.80700809 |
| 158 | Hyperphosphaturia (HP:0003109) | 1.79865268 |
| 159 | Posterior subcapsular cataract (HP:0007787) | 1.79860977 |
| 160 | Elevated alkaline phosphatase (HP:0003155) | 1.79701324 |
| 161 | Elevated hepatic transaminases (HP:0002910) | 1.79389419 |
| 162 | Esophageal varix (HP:0002040) | 1.79185330 |
| 163 | Abnormality of the renal cortex (HP:0011035) | 1.72572872 |
| 164 | Abnormality of the prostate (HP:0008775) | 1.70248360 |
| 165 | Nausea (HP:0002018) | 1.68513717 |
| 166 | Abnormality of homocysteine metabolism (HP:0010919) | 1.67147382 |
| 167 | Homocystinuria (HP:0002156) | 1.67147382 |
| 168 | Pancytopenia (HP:0001876) | 1.66641720 |
| 169 | Hypomagnesemia (HP:0002917) | 1.64175706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.34324793 |
| 2 | TIE1 | 4.30495135 |
| 3 | MST4 | 3.85470767 |
| 4 | ERBB4 | 3.80355823 |
| 5 | MAP3K12 | 3.53204867 |
| 6 | FGFR4 | 3.38114710 |
| 7 | SIK1 | 3.20457300 |
| 8 | PBK | 2.85601269 |
| 9 | EIF2AK3 | 2.78402999 |
| 10 | OXSR1 | 2.52389013 |
| 11 | WNK4 | 2.50063546 |
| 12 | STK38L | 2.38435307 |
| 13 | ERN1 | 2.36381368 |
| 14 | INSRR | 2.29512479 |
| 15 | STK39 | 2.26234581 |
| 16 | TAOK3 | 2.24688569 |
| 17 | ADRBK2 | 2.14132551 |
| 18 | ZAK | 2.10020832 |
| 19 | LATS1 | 1.93560128 |
| 20 | WNK3 | 1.93503179 |
| 21 | MAP4K2 | 1.81199766 |
| 22 | MST1R | 1.72563537 |
| 23 | MAPK11 | 1.70654725 |
| 24 | TLK1 | 1.68399998 |
| 25 | PDK2 | 1.64741536 |
| 26 | ABL2 | 1.59702221 |
| 27 | MET | 1.58876506 |
| 28 | PINK1 | 1.58149826 |
| 29 | FGFR2 | 1.56564254 |
| 30 | TESK2 | 1.55031516 |
| 31 | STK16 | 1.52470186 |
| 32 | MYLK | 1.47971566 |
| 33 | TEC | 1.45756923 |
| 34 | TRIM28 | 1.44731071 |
| 35 | MAP2K4 | 1.40881932 |
| 36 | NEK9 | 1.39969239 |
| 37 | PIK3CG | 1.39564799 |
| 38 | TSSK6 | 1.38445338 |
| 39 | SGK223 | 1.32465070 |
| 40 | SGK494 | 1.32465070 |
| 41 | ERBB3 | 1.27514319 |
| 42 | SRPK1 | 1.22967777 |
| 43 | TXK | 1.17883561 |
| 44 | FLT3 | 1.15023848 |
| 45 | KDR | 1.12561509 |
| 46 | EPHB1 | 1.10951354 |
| 47 | VRK2 | 1.10751193 |
| 48 | PLK3 | 1.07718016 |
| 49 | MUSK | 1.04214116 |
| 50 | GRK1 | 1.03745409 |
| 51 | EIF2AK1 | 1.01516802 |
| 52 | CSNK1G1 | 1.01160611 |
| 53 | WEE1 | 1.00728835 |
| 54 | CSNK1G3 | 0.95656507 |
| 55 | PRKAA2 | 0.95419096 |
| 56 | MKNK1 | 0.95362880 |
| 57 | MKNK2 | 0.94828377 |
| 58 | LIMK1 | 0.92430952 |
| 59 | NEK1 | 0.90153818 |
| 60 | ERBB2 | 0.84682748 |
| 61 | BCR | 0.84382034 |
| 62 | BMX | 0.83724892 |
| 63 | GRK7 | 0.82617409 |
| 64 | CAMK1D | 0.80636032 |
| 65 | SGK2 | 0.79765797 |
| 66 | PLK2 | 0.79416888 |
| 67 | MAPKAPK5 | 0.78752206 |
| 68 | BUB1 | 0.78751130 |
| 69 | CSNK1A1L | 0.78685907 |
| 70 | CAMK2G | 0.78114185 |
| 71 | BRSK2 | 0.77976940 |
| 72 | PRKCZ | 0.77628931 |
| 73 | CDK19 | 0.77200665 |
| 74 | FRK | 0.75727456 |
| 75 | PTK6 | 0.74525813 |
| 76 | CSNK1G2 | 0.73437733 |
| 77 | VRK1 | 0.72834712 |
| 78 | PKN1 | 0.72819885 |
| 79 | MATK | 0.71648374 |
| 80 | STK24 | 0.69470265 |
| 81 | PDK4 | 0.69110518 |
| 82 | PDK3 | 0.69110518 |
| 83 | DYRK2 | 0.68310715 |
| 84 | EPHA4 | 0.68231105 |
| 85 | MAPK4 | 0.67781661 |
| 86 | EIF2AK2 | 0.67558969 |
| 87 | SGK3 | 0.67456396 |
| 88 | IKBKB | 0.66637157 |
| 89 | TYK2 | 0.66257998 |
| 90 | SCYL2 | 0.66172448 |
| 91 | ICK | 0.65157475 |
| 92 | NME1 | 0.64042922 |
| 93 | PRKACG | 0.63680367 |
| 94 | GRK6 | 0.63139641 |
| 95 | PRKCE | 0.62370223 |
| 96 | MAPKAPK3 | 0.61917735 |
| 97 | PRKG2 | 0.61238468 |
| 98 | PRKAA1 | 0.61007391 |
| 99 | IRAK2 | 0.60547978 |
| 100 | NME2 | 0.59810741 |
| 101 | TRPM7 | 0.59024023 |
| 102 | ADRBK1 | 0.58764274 |
| 103 | GSK3A | 0.58498244 |
| 104 | TGFBR1 | 0.57787699 |
| 105 | DAPK1 | 0.56617243 |
| 106 | MAP3K11 | 0.55623918 |
| 107 | PRKCQ | 0.53802822 |
| 108 | PRKCG | 0.53441951 |
| 109 | CSNK2A1 | 0.52837565 |
| 110 | PLK1 | 0.52653664 |
| 111 | BRAF | 0.51956796 |
| 112 | LYN | 0.51577378 |
| 113 | MAP3K7 | 0.50914197 |
| 114 | TNIK | 0.50837835 |
| 115 | TTK | 0.50545830 |
| 116 | ALK | 0.49759964 |
| 117 | OBSCN | 0.48231605 |
| 118 | CSNK2A2 | 0.47760074 |
| 119 | BMPR1B | 0.47547545 |
| 120 | MAPK13 | 0.47319254 |
| 121 | RPS6KA5 | 0.47063296 |
| 122 | BMPR2 | 0.46047266 |
| 123 | CSNK1A1 | 0.45530100 |
| 124 | ACVR1B | 0.45341306 |
| 125 | LATS2 | 0.44270372 |
| 126 | JAK2 | 0.43677351 |
| 127 | SYK | 0.43092617 |
| 128 | MAPK12 | 0.42855969 |
| 129 | CDK6 | 0.42262805 |
| 130 | CHEK2 | 0.40840028 |
| 131 | DAPK2 | 0.39609038 |
| 132 | ILK | 0.38310036 |
| 133 | IGF1R | 0.37016220 |
| 134 | NEK6 | 0.36792726 |
| 135 | PDPK1 | 0.36224073 |
| 136 | DYRK1B | 0.35944508 |
| 137 | ITK | 0.35821767 |
| 138 | AKT3 | 0.35729854 |
| 139 | IRAK1 | 0.34914013 |
| 140 | ABL1 | 0.34862147 |
| 141 | CAMK2D | 0.34844741 |
| 142 | MAPK7 | 0.34277960 |
| 143 | PRKCI | 0.33627806 |
| 144 | MAP3K14 | 0.33627237 |
| 145 | AURKB | 0.33515091 |
| 146 | ATR | 0.32600670 |
| 147 | PTK2 | 0.32275460 |
| 148 | STK3 | 0.31926285 |
| 149 | PRKCA | 0.30593588 |
| 150 | TAOK2 | 0.30324144 |
| 151 | PRKACB | 0.28734833 |
| 152 | PRKACA | 0.25274396 |
| 153 | MAP2K1 | 0.24885221 |
| 154 | PAK3 | 0.23325960 |
| 155 | PLK4 | 0.22527811 |
| 156 | CAMK1G | 0.22503965 |
| 157 | NUAK1 | 0.21874113 |
| 158 | AKT2 | 0.21214331 |
| 159 | FGFR1 | 0.21087910 |
| 160 | CSNK1E | 0.19915258 |
| 161 | MAP2K6 | 0.19851460 |
| 162 | PIK3CA | 0.19690901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.13949666 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18325340 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11986694 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.89922996 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.89742086 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78444590 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72141424 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.71427061 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64619868 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62588106 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50329381 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.48861285 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.39648925 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.38492964 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.37849310 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.27829589 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20581456 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15993873 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13383120 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95719009 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95101093 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87208177 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87079149 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83998287 |
| 25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.81729274 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80162803 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79049469 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.77726328 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74710986 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74514200 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69561329 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67567229 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.62652363 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60217134 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59194144 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57510135 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57398615 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.55120731 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.55044451 |
| 40 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52503230 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.51941542 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.51037885 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49300813 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48469500 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.46071766 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43417011 |
| 47 | RNA polymerase_Homo sapiens_hsa03020 | 1.40512919 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40175160 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39101540 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35916091 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34223561 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32785517 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24617274 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24474905 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23247187 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.22280321 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21430382 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21051204 |
| 59 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.16519982 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14542263 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13670636 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13238267 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09763990 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05038597 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02777913 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02461258 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02172723 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01680540 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98577221 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.98055363 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97113130 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95011181 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94672757 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91984004 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91415848 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85807503 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85147842 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.82859121 |
| 79 | Mismatch repair_Homo sapiens_hsa03430 | 0.81598192 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.81520458 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79475031 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79032572 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.75925491 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71685682 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71107649 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68645889 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.68424394 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66048987 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64143971 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63062693 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62756847 |
| 92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60806477 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58165976 |
| 94 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57267004 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.56085727 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54553788 |
| 97 | DNA replication_Homo sapiens_hsa03030 | 0.48637332 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48004779 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45407475 |
| 100 | RNA transport_Homo sapiens_hsa03013 | 0.44110472 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43692379 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41077886 |
| 103 | Spliceosome_Homo sapiens_hsa03040 | 0.40953605 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.40195095 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38000192 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.27422051 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21994152 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19234658 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13281698 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11027202 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07594138 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05628590 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01981145 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.01739577 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.01719837 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01235191 |
| 117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.00682618 |
| 118 | Protein export_Homo sapiens_hsa03060 | -0.2317678 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2186785 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | -0.2130848 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | -0.2015282 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1814242 |
| 123 | Proteasome_Homo sapiens_hsa03050 | -0.1757754 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1688928 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1675295 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1605849 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1589619 |
| 128 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1272751 |
| 129 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1250020 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1059684 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0744165 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0708319 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | -0.0669663 |
| 134 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0183024 |

